ClinAssess GmbH   Report issue

For profit Phase 2 Phase 3
Founded: Leverkusen Germany (2000)

Organization Overview

First Clinical Trial
2009
NCT01449344
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ClinAssess GmbH